Controlling multidrug-resistant Gram-negative bacilli in your hospital: a transformational journey

The Journal of Hospital Infection
L Silvia Munoz-Price

Abstract

During the past two decades, the world has experienced a proliferation of multidrug-resistant Gram-negative organisms. This paper is an account of the author's personal experience of implementing a bundle of interventions aimed at controlling carbapenem-resistant Acinetobacter baumannii, and of the cultural transformation that was required for effective control.

References

Jan 5, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Philip C CarlingDeborah Highlander
Jun 24, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Kirk HuslageDavid J Weber
Apr 5, 2011·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·L Silvia Munoz-PriceCameron Dezfulian
Jan 10, 2012·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·L Silvia Munoz-PriceKristopher L Arheart
Mar 20, 2012·Critical Care Medicine·Robert A Weinstein
Apr 11, 2013·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·L Silvia Munoz-PriceYohei Doi
Jun 29, 2013·Current Opinion in Infectious Diseases·L Silvia Munoz-Price, John P Quinn
Aug 24, 2013·The Lancet Infectious Diseases·L Silvia Munoz-PriceJohn P Quinn
Aug 29, 2013·Critical Care Medicine·L Silvia Munoz-PriceLaurent Poirel
Dec 18, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E TacconelliUNKNOWN European Society of Clinical Microbiology
May 6, 2014·American Journal of Infection Control·Rossana RosaL Silvia Munoz-Price

❮ Previous
Next ❯

Citations

Apr 6, 2016·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Luis A ShimoseL Silvia Munoz-Price
Mar 17, 2015·The Journal of Hospital Infection·A M Walker
Aug 16, 2016·Infectious Disease Clinics of North America·Philip C Carling
Feb 9, 2017·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P BarbadoroM M D'Errico
Aug 8, 2021·Infectious Disease Clinics of North America·Philip C Carling

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Related Papers

Emerging Infectious Diseases
Vladimir Krcmery, Erich Kalavsky
The Journal of Antimicrobial Chemotherapy
Rohini J ManuelRichard Holliman
Emerging Infectious Diseases
Thierry NaasPatrice Nordmann
Canadian Family Physician Médecin De Famille Canadien
Joseph Lee
© 2021 Meta ULC. All rights reserved